Kozak & Associates’s Medtronic MDT Stock Holding History

Kozak & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$158	Hold	2	–	–	﹤0.01%	413
2026 Q1	$176	Hold	2	–	–	﹤0.01%	422
2025 Q4	$195	Hold	2	–	–	﹤0.01%	407
2025 Q3	$193	Sell	2 -64	-97%	-$5.88K	﹤0.01%	429
2025 Q2	$5.87K	Hold	66	–	–	﹤0.01%	278
2025 Q1	$5.56K	Hold	66	–	–	﹤0.01%	280
2024 Q4	$5.34K	Buy	66 +64	+3,200%	+$5.54K	﹤0.01%	289
2024 Q3	$180	Hold	2	–	–	﹤0.01%	370
2024 Q2	$154	Sell	2 -30	-94%	-$2.46K	﹤0.01%	366
2024 Q1	$2.74K	Sell	32 -326	-91%	-$27.8K	﹤0.01%	310
2023 Q4	$31K	Sell	358 -465	-57%	-$35.4K	0.01%	164
2023 Q3	$62.6K	Buy	823 +30	+4%	+$2.51K	0.02%	120
2023 Q2	$69.1K	Hold	793	–	–	0.03%	122
2023 Q1	$63.9K	Hold	793	–	–	0.03%	131
2022 Q4	$62K	Hold	793	–	–	0.03%	130
2022 Q3	$65K	Hold	793	–	–	0.04%	126
2022 Q2	$71K	Hold	793	–	–	0.05%	126
2022 Q1	$83K	Hold	793	–	–	0.05%	125
2021 Q4	$83K	Hold	793	–	–	0.05%	125
2021 Q3	$93K	Buy	+793	New	+$103K	0.06%	117

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kozak & Associates's MDT Position: Q2 2026 in Review

Kozak & Associates held its Medtronic (MDT) position steady in Q2 2026 at 2 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Kozak & Associates first reported a position in MDT in Q3 2021 and has held it in 20 quarters since. The position peaked at $93K in Q3 2021. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Kozak & Associates held 2 shares of Medtronic worth $158 as of Q2 2026.
Kozak & Associates left its Medtronic share count unchanged in Q2 2026.
Medtronic made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #413 holding.
Kozak & Associates first reported a position in Medtronic in Q3 2021 and has held it in 20 quarters since.
Kozak & Associates's Medtronic position peaked at $93K in Q3 2021.
2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.